Oluremi Tinubu launches HIV/AIDS campaign, urges support for patients, end to stigma

1 minute read

By Kunle Sanni

First Lady Oluremi Tinubu has launched the Free to Shine Triple Elimination Campaign in Nigeria’s South-South geopolitical zone, urging Nigerians to support those living with HIV/AIDS and put an end to stigmatization.

She emphasized that eliminating the disease by 2030 is achievable through collective efforts, awareness, and access to treatment.

The campaign, an initiative of the Organization of African First Ladies for Development (OAFLAD), aims to reduce new HIV infections among women of reproductive age, prevent mother-to-child transmission, and ensure that children born with HIV receive the necessary care and support.

During the campaign flag-off, Senator Tinubu stressed the need for Nigeria to join other African nations that have met the UNAIDS 95-95-95 target—a global strategy ensuring that 95% of people living with HIV know their status, 95% receive treatment, and 95% achieve viral suppression.

According to the Federal Ministry of Health and Social Welfare, over 100,000 children and nearly 2 million adults in Nigeria are currently living with HIV. Many infants born to HIV-positive mothers do not receive early testing, largely due to a lack of awareness and the consequences of delayed diagnosis.

“It is heartbreaking to learn that just two years ago, 15,000 children between the ages of 0 and 14 died from AIDS-related illnesses. Each of these children represented not just a statistic, but a future full of potential that was sadly cut short,” the First Lady said.

She called for renewed commitment from all Nigerians, stressing that HIV is not a death sentence and that testing and early treatment can ensure a healthier life.

Addressing concerns about access to treatment, the Minister of State for Health and Social Welfare, Iziaq Salako, dismissed rumors of a scarcity of antiretroviral drugs in Nigeria. He noted that HIV, syphilis, and hepatitis continue to pose significant challenges, particularly in maternal and child health.